Tocqueville Asset Management L.P. Sangamo Therapeutics, Inc Transaction History

Tocqueville Asset Management L.P.

$6.27 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	SELL	$0.3 - $0.63 $120 - $252	-400 Reduced 2.71%	14,380 $7,000
Q2 2023 Aug 11, 2023	SELL	$1.11 - $1.74 $3,108 - $4,872	-2,800 Reduced 15.93%	14,780 $19,000
Q2 2022 Aug 12, 2022	SELL	$3.28 - $6.21 $6,560 - $12,420	-2,000 Reduced 10.21%	17,580 $73,000
Q4 2021 Feb 14, 2022	SELL	$7.29 - $10.97 $36,450 - $54,850	-5,000 Reduced 20.34%	19,580 $147,000
Q3 2021 Nov 15, 2021	SELL	$9.01 - $12.01 $11,172 - $14,892	-1,240 Reduced 4.8%	24,580 $221,000
Q2 2021 Aug 16, 2021	SELL	$10.17 - $12.64 $2,745 - $3,412	-270 Reduced 1.03%	25,820 $309,000
Q1 2021 May 17, 2021	SELL	$10.88 - $17.05 $1,632 - $2,557	-150 Reduced 0.57%	26,090 $327,000
Q4 2020 Feb 16, 2021	SELL	$9.23 - $18.18 $103,376 - $203,616	-11,200 Reduced 29.91%	26,240 $409,000
Q3 2020 Nov 16, 2020	SELL	$9.38 - $12.48 $11,256 - $14,976	-1,200 Reduced 3.11%	37,440 $354,000
Q2 2020 Aug 12, 2020	SELL	$6.21 - $11.83 $565,824 - $1.08 Million	-91,115 Reduced 70.22%	38,640 $346,000
Q1 2020 May 15, 2020	SELL	$5.05 - $8.85 $26,159 - $45,843	-5,180 Reduced 3.84%	129,755 $827,000
Q4 2019 Jan 14, 2020	BUY	$8.03 - $11.7 $497,418 - $724,756	61,945 Added 84.87%	134,935 $1.13 Million
Q3 2019 Oct 31, 2019	SELL	$9.05 - $12.22 $622,160 - $840,088	-68,747 Reduced 48.5%	72,990 $661,000
Q2 2019 Jul 31, 2019	BUY	$8.75 - $13.03 $5,250 - $7,818	600 Added 0.43%	141,737 $1.53 Million
Q1 2019 Apr 30, 2019	BUY	$7.72 - $12.81 $170,612 - $283,101	22,100 Added 18.57%	141,137 $1.35 Million
Q4 2018 Feb 08, 2019	SELL	$9.51 - $16.6 $5.63 Million - $9.83 Million	-592,200 Reduced 83.26%	119,037 $1.37 Million
Q3 2018 Nov 13, 2018	BUY	$13.05 - $19.05 $4.83 Million - $7.05 Million	370,297 Added 108.61%	711,237 $12.1 Million
Q2 2018 Aug 13, 2018	BUY	$13.9 - $19.8 $426,730 - $607,860	30,700 Added 9.9%	340,940 $4.84 Million
Q1 2018 May 14, 2018	SELL	$16.7 - $26.35 $5.94 Million - $9.37 Million	-355,650 Reduced 53.41%	310,240 $5.9 Million
Q4 2017 Feb 13, 2018	BUY	$11.6 - $17.35 $3.96 Million - $5.92 Million	341,075 Added 105.01%	665,890 $10.9 Million
Q3 2017 Oct 30, 2017	BUY	$8.4 - $15.0 $2.73 Million - $4.87 Million	324,815	324,815 $4.87 Million

Others Institutions Holding SGMO

# of Institutions

111

Shares Held

56.7M

Call Options Held

576K

Put Options Held

1.17M

Wasatch Advisors Inc Salt Lake City, UT

19.4M
Shares

$23.9 Million
0.08% of portfolio
Vanguard Group Inc Valley Forge, PA

9.6M
Shares

$11.8 Million
0.0% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

4.85M
Shares

$5.97 Million
0.01% of portfolio
Black Rock Inc. New York, NY

4.7M
Shares

$5.78 Million
0.0% of portfolio
Marshall Wace, LLP London, X0

2.35M
Shares

$2.9 Million
0.0% of portfolio

View Full List

About SANGAMO THERAPEUTICS, INC

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $193M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

More about SGMO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tocqueville Asset Management L.P., based on Form 13F filings with the SEC.

News

Stay updated on Tocqueville Asset Management L.P. with notifications on news.

Account